史娄,宇轩,邹花一阳,孔祥清

• 1:南京医科大学第一附属医院心血管内科

摘要(Abstract)：

高血压病是目前最常见的慢性非传染性疾病,全球患病率呈逐年上升趋势。目前原发性高血压仍以药物治疗为主,但因患者难以长期坚持服用药物导致控制率低,因此需要其他安全、有效、经济的非药物治疗来达到控制高血压的目的。自1978年首例肾血管性高血压病介入治疗获得成功后,介入治疗不断应用于治疗高血压病。目前针对原发性高血压的介入治疗尝试众多,去肾交感神经术、颈动脉窦压力感受器刺激、髂中央动静脉吻合术、脑神经深度刺激等成为目前研究的热点,多项临床试验和随机对照研究提示介入治疗具有明显的降压效果,但仍需要更多的研究来检验其安全性及可靠性。本文将对以上介入治疗方法进行综述,为原发性高血压的介入治疗提供参考。

关键词(KeyWords)： 继发性高血压;原发性高血压;介入治疗

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 史娄,宇轩,邹花一阳,孔祥清

参考文献(References)：

• [1]Yang T,Zubcevic J.Gut-brain axis in regulation of blood pressure.Front Physiol,2017,8:845.
• [2]中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2019概要.中国循环杂志，2020,35(9):833-854.
• [3]祖凌云，郭丽君.肾交感神经消融术治疗顽固性高血压的现状与未来.中国心血管杂志，2013,18(6):420-422.
• [4]S?rensen R,Grüntzig A,Apitzsch DE,et al.Transluminal angioplasty of renal artery stenosis for the treatment of renal hypertension (author's transl).Rofo,1979,131(6):575-580.
• [5]Grassi G,Mark A,Esler M.The sympathetic nervous system alterations in human hypertension.Circ Res,2015,116(6):976-990.
• [6]Grassi G,Seravalle G,Brambilla G,et al.The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension:a focus on renal denervation.Can J Cardiol,2012,28(3):311-317.
• [7]Krum H,Schlaich M,Whitbourn R,et al.Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study.Lancet,2009,373(9671):1275-1281.
• [8]Symplicity HTN-2 Investigators,Esler MD,Krum H,et al.Renal sympathetic denervation in patients with treatmentresistant hypertension (The Symplicity HTN-2 Trial):a randomised controlled trial.Lancet,2010,376(9756):1903-1909.
• [9]Bhatt DL,Kandzari DE,O’eill WW,et al.A controlled trial of renal denervation for resistant hypertension.N Engl J Med,2014,370(15):1393-1401.
• [10]Mabin T,Sapoval M,Cabane V,et al.First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension.EuroIntervention,2012,8(1):57-61.
• [11]Worthley SG,Tsioufis CP,Worthley MI,et al.Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension:the EnligHTN I trial.Eur Heart J,2013,34(28):2132-2140.
• [12]Townsend RR,Mahfoud F,Kandzari DE,et al.Catheter based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications(SPYRAL HTN-OFF MED):a randomised,shamcontrolled,proof-of-concept trial.Lancet,2017,390(10108):2160-2170.
• [13]Azizi M,Schmieder RE,Mahfoud F,et al.Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO):a multicentre,international,single-blind,randomised,sham-controlled trial.Lancet,2018,391(10137):2335-2345.
• [14]Lauder L,Wolf MA,Scholz SS,et al.Renal denervation:is it ready for prime time?Curr Cardiol Rep,2019,21(8):80.
• [15]Mahfoud F,Mancia G,Schmieder R,et al.Renal denervation in high-risk patients with hypertension.J Am Coll Cardiol,2020,75(23):2879-2888.
• [16]Mahfoud F,Schmieder RE,Azizi M,et al.Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension:state of the art and considerations for the future.Eur Heart J,2017,38(44):3272-3281.
• [17]de Leeuw PW,Alnima T,Lovett E,et al.Bilateral or unilateral stimulation for baroreflex activation therapy.Hypertension,2015,65(1):187-192.
• [18]Spiering W,Williams B,Van der Heyden J,et al.Endovascular baroreflex amplification for resistant hypertension:a safety and proof-of-principle clinical study.Lancet,2017,390(10113):2655-2661.
• [19]Lobo MD,Sobotka PA,Stanton A,et al.Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study):a randomised controlled trial.Lancet,2015,385(9978):1634-1641.
• [20]Lobo MD,Ott C,Sobotka PA,et al.Central iliac arteriovenous anastomosis for uncontrolled hypertension:one-year results from the ROX CONTROL HTN Trial.Hypertension,2017,70(6):1099-1105.
• [21]季淑梅，孙心平，张卫，等.心血管各级中枢的血压调节作用.生物医学工程学杂志，2009,26(1):216-220.
• [22]Green AL,Wang S,Bittar RG,et al.Deep brain stimulation:a new treatment for hypertension?J Clin Neurosci,2007,14(6):592-595.
• [23]Patel NK,Javed S,Khan S,et al.Deep brain stimulation relieves refractory hypertension.Neurology,2011,76(4):405-407.
• [24]Carter HH,Dawson EA,Cable NT,et al.Deep brain stimulation of the periaqueductal grey induces vasodilation in humans.Hypertension,2011,57(5):e24-e25.
• [25]O’Callaghan EL,Hart EC,Sims-Williams HJ,et al.Chronic deep brain stimulation decreases blood pressure and sympathetic nerve activity in a drug-and device-resistant hypertensive patient.Hypertension,2017,69(4):522-528.